DTL
ATRA icon

Dynamic Technology Lab’s Atara Biotherapeutics ATRA Stock Holding History

Dynamic Technology Lab’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-477
Closed -$17K – 1033
2023
Q3 		$17K Buy
+477
New +$21.2K ﹤0.01% 907
2022
Q4 		– Sell
-1,361
Closed -$129K – 1088
2022
Q3 		$129K Buy
+1,361
New +$153K 0.01% 1000
2021
Q2 		– Sell
-604
Closed -$217K – 1123
2021
Q1 		$217K Buy
+604
New +$267K 0.02% 919
2020
Q4 		– Sell
-630
Closed -$204K – 972
2020
Q3 		$204K Buy
+630
New +$215K 0.03% 799
2018
Q3 		– Sell
-395
Closed -$363K – 1010
2018
Q2 		$363K Buy
+395
New +$424K 0.05% 590

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dynamic Technology Lab's ATRA Position: Q4 2023 in Review

Dynamic Technology Lab sold out of Atara Biotherapeutics (ATRA) in Q4 2023, closing a stake of 477 shares — an estimated $17K sold.

Dynamic Technology Lab first reported a position in ATRA in Q2 2018 and held it in 5 quarters. The position peaked at $363K in Q2 2018. 90 funds tracked by Wall St. Rank hold ATRA as of Q4 2023.

  • Dynamic Technology Lab reported no remaining Atara Biotherapeutics position as of Q4 2023 after selling out during the quarter.
  • Dynamic Technology Lab sold 477 Atara Biotherapeutics shares in Q4 2023, an estimated $17K.
  • Dynamic Technology Lab first reported a position in Atara Biotherapeutics in Q2 2018 and held it in 5 quarters.
  • Dynamic Technology Lab's Atara Biotherapeutics position peaked at $363K in Q2 2018.
  • 90 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q4 2023.

Based on Dynamic Technology Lab's 13F filing for Q4 2023, filed 9 Feb 2024.